ARJUNLAL KAKRANI

Employment

• Dr D Y Patil Vidyapeeth University Dr D Y Patil Medical College Hospital and Research Centre Professor of Eminence in Medicine & Director, Academic Collaborations
  2020 - Present
• Dr D Y Patil Vidyapeeth University Dr D Y Patil Medical College Hospital and Research Centre Professor & Head, Department of Medicine
  2008 - 2020
• Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals Professor of Medicine
  1989 - 2008
• Government Medical College Miraj Associate Professor
  1977 - 1989

Education

• MGM MEDICAL COLLEGE MD
  1967 - 1976

Projects & Funding

Projects & funding information is unavailable.

Publications (84)

• Post-tuberculosis lung disease in treated extra-pulmonary tuberculosis
  American Journal of Respiratory and Critical Care Medicine 2026 1 citation DOI: 10.1093/ajrccm/aamag107
  +Save
• Efficacy of Balance Training and Motor Coordination Exercises on Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
  Journal of Datta Meghe Institute of Medical Sciences University 2025 0 citations DOI: 10.4103/jdmimsu.jdmimsu_269_24
  +Save
• Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
  Eclinicalmedicine 2025 3 citations DOI: 10.1016/j.eclinm.2025.103080
  +Save
• Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  Lancet Infectious Diseases 2025 11 citations DOI: 10.1016/S1473-3099(25)00093-3
  +Save
• Assessment of Anti-spike and Neutralizing Antibody Response Against SARS-CoV-2 after Covishield and CovaxinTM Vaccination
  Medical Journal of Dr D Y Patil Vidyapeeth 2024 0 citations DOI: 10.4103/mjdrdypu.mjdrdypu_385_23
  +Save
• Correction: Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household con…
  Trials 2024 2 citations DOI: 10.1186/s13063-024-07984-3
  +Save
• Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India
  Human Vaccines and Immunotherapeutics 2024 4 citations DOI: 10.1080/21645515.2024.2410579
  +Save
• T-cell responses in COVID-19 survivors 6−8 months after infection: A longitudinal cohort study in Pune
  Immunity Inflammation and Disease 2024 2 citations DOI: 10.1002/iid3.1238
  +Save
• Early Microbiologic Markers of Pulmonary Tuberculosis Treatment Outcomes
  Annals of the American Thoracic Society 2023 6 citations DOI: 10.1513/AnnalsATS.202302-144OC
  +Save
• Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study
  Lancet Regional Health Southeast Asia 2023 11 citations DOI: 10.1016/j.lansea.2022.100139
  +Save